PSA doubling time useful in patients on `observation'

Hannapel, Coriene E.
April 2000
Urology Times;Apr2000, Vol. 28 Issue 4, p15
Reports that PSA doubling time may be used in directing treatment for prostate cancer patients who are managed with observation. Toronto, Ontario-based Toronto-Sunnybrook Regional Cancer Centre researcher Gerrit DeBoer's presentation at the American Society for Therapeutic Radiology and Oncology's year 2000 meeting.


Related Articles

  • CALENDAR AND EVENTS.  // Canadian Urological Association Journal;Jun2010, Vol. 4 Issue 3, p219 

    A calendar of events related organized by Canadian Urological Association (CUA) in 2010 is presented which includes the 64th Annual Meeting of the CUA: Educational Forum 5 New Developments in Prostate Cancer Risk Reduction, the Management of Prostate Disease in Canada: Perception, Evidence and...

  • Italian urologists back HIFU.  // Medical Device Daily;4/14/2009, Vol. 13 Issue 70, p7 

    The article reports that the Association of Italian Urologists (AURO) has recommended high-intensity focused ultrasound (HIFU) as a standard of care for the treatment of prostate cancer. It states the recommendation and updated guidelines are based on the number of HIFU patients treated in...

  • Selenium: THE ONGOING CONTROVERSY. Runestad, Todd // Functional Ingredients;Sep2009, Issue 90, p32 

    The article focuses on the issues regarding the health claim of selenium on prostate cancer. It presents the contrasting results of the 1996 and 2009 Journal of the American Medical Association (JAMA) studies on selenium. According to the 1996 study, selenium reduces the risk of prostate cancer...

  • Early prostate cancer best left alone--Treatment riskier than cancer.  // HealthFacts;Jul93, Vol. 18 Issue 170, p1 

    Reports on the modalities of treating prostatic cancer. Prostate Patient Outcomes Research Team; Radical prostatectomy; Prostate-specific antigen blood test; Radiation therapy; Watchful waiting; Nerve-sparing technique.

  • Patients say they want aggressive treatment for prostate cancer.  // Modern Medicine;Jul96, Vol. 64 Issue 7, p31 

    Reports that a Harris Poll survey of 1,000 newly diagnosed patients has found that men who have prostate cancer want the most aggressive therapy available. Other survey results.

  • Prostate-cancer vaccine.  // Men's Health;Jul/Aug97, Vol. 12 Issue 6, p126 

    Presents information about prostate-cancer vaccine. Effectivity of the vaccine; Effect of a cancerous prostate cells left after surgery; Testing the vaccine in patients whose cancer has returned after surgery.

  • PSA results refute objections to perineal prostatectomy. Kuznar, Wayne // Urology Times;Jan95, Vol. 23 Issue 1, p22 

    Reports on the effectiveness of radical prostatectomy as a treatment for localized prostate cancer as indicated by postoperative prostate-specific antigen (PSA) levels. Criticism of perineal approach; Retropubic approach; Limiting factor to radical perineal prostatectomy.

  • Sr 89 injection eases prostate cancer pain.  // Urology Times;Dec95, Vol. 23 Issue 12, p17 

    Reports on an article published in the June 1993 issue of `Seminars in Oncology' about a drug that reduces the pain experienced by prostate cancer patients.

  • Concern grows over prostate cancer treatment options. Parkins, Troy // JNCI: Journal of the National Cancer Institute;6/15/94, Vol. 86 Issue 12, p897 

    Reports on the benefits and limitations of various treatment options for prostate cancer. Popularity of radical prostatectomy; Effectiveness of cryosurgery over radiation; Concerns of doctors on cryosurgery; Side effects of prostate cancer treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics